It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Learn what customers are saying about no annual fee travel credit cards. Gain insights to help you choose the right card for your travels.
22,936 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Venture funding in the U.S. hit a record in the first half of 2026, led by AI mega-deals, while exits skew toward Spa...
Netflix signals a major strategic shift toward live television and third-party distributions to boost engagement as a...
A large IRA move at 63 can trigger higher Medicare premiums for years, thanks to a two year income lookback. Near ret...
Ark Invest's Cathie Wood is signaling a bold stance by scooping up Coinbase and Circle during a crypto sell-off. This...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
Bitcoin steadied near the $60,000 level as tensions in the Strait of Hormuz pushed oil higher and equity futures retr...
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...
Mortgage lenders are moving AI from experimentation to enterprise deployment in 2026. Addy AI's Michael Vandi explain...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
A misdirected public-comment inbox is stirring confusion over the SEC's plan to scrap quarterly reporting. Officials ...